BRIEF NOTE
O tratamento da hidrocefalia de pressão normal (HPN) envolve testes clínicos, radiológicos e especiais para o diagnóstico e shunt do líquido cefalorraquidiano (LCR) em pacientes adequadamente selecionados. O tratamento cirúrgico deve ser oferecido aos pacientes selecionados através da análise de vários meios disponíveis à nossa disposição para prever a resposta ao shunt.
Management of normal pressure hydrocephalus (NPH) involves clinical, radiological and special tests for the diagnosis and cerebrospinal fluid (CSF) diversion in appropriately selected patients. Surgical treatment should be offered to patients selected by analyzing various means available for predicting shunt responsiveness.
2. Virhammar J, Laurell K, Cesarini KG, Larsson EM. Preoperative Prognostic Value of MRI Findings in 108 Patients with Idiopathic Normal Pressure Hydrocephalus. AJNR Am J Neuroradiol. 2014;35(12):2311-8. http://doi.org/10.3174/ajnr.A4046. PMid:25012669.
3. Hashimoto M, Ishikawa M, Mori E, Kuwana N, Study Of Inph On Neurological Improvement (SINPHONI). The study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010;7(1):18. http:// doi.org/10.1186/1743-8454-7-18. PMid:21040519.
4. Walchenbach R, Geiger E, Thomeer R, Vanneste J. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2002;72(4):503-6. PMid:11909911.
5. Haan J, Thomeer RT. Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus. Neurosurgery. 1988;22:38891. http://doi.org/10.1227/00006123-198802000-00020. PMid:3352890.
6. Williams MA, Razumovsky AY, Hanley DF. Comparison of PCSF monitoring and controlled CSF drainage to diagnose normal pressure hydrocephalus. Acta Neurochir Suppl (Wien). 1998;71:328-30. http:// doi.org/10.1007/978-3-7091-6475-4_95. PMid:9779221.
7. Takeuchi T, Kasahara E, Iwasaki M, Mima T, Mori K. Indications for shunting in patients with idiopathic normal pressure hydrocephalus presenting with dementia and brain atrophy. Neurol Med Chir (Tokyo). 2000;40(1):38-47, discussion 46-7. http://doi.org/10.2176/nmc.40.38. PMid:10721254.
8. Boon AJ, Tans JT, Delwel EJ, et al. The Dutch normal-pressure hydrocephalus study. How to select patients for shunting? An analysis of four diagnostic criteria. Surg Neurol. 2000;53(3):201-7. http://doi. org/10.1016/S0090-3019(00)00182-8. PMid:10773249.
9. Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015;85(23):2063-71. http://doi.org/10.1212/WNL.0000000000002193. PMid:26644048.
10. Wikkels C, Hellström P, Klinge PM, Tans JTJ. European iNPH Multicentre Study Group. The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2013;84(5):562-8. http://doi.org/10.1136/jnnp2012-303314. PMid:23250963.
11. Marmarou A, Bergsneider M,Klinge P, Relkin N, Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathicnormal-pressure hydrocephalus. Neurosurgery.
2005;57(3 Suppl):S17-28; discussion ii-v. http://doi.org/10.1227/01. neu.0000168184.01002.60. PMid:16160426.
12. Nakajima M, Yamada S, Miyajima M, et al. Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo). 2021; 61(2):63-97. http:// doi.org/10.2176/nmc.st.2020-0292. PMid:33455998.
13. Kazui H, Miyajima M, Mori E, Ishikawa M, SINPHONI-2 INVESTIGATORS. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial. Lancet Neurol. 2015;14(6):585-94. http://doi.org/10.1016/S14744422(15)00046-0. PMid:25934242.
14. Tudor KI, Tudor M, McCleery J, Car J. Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH). Cochrane Database Syst Rev. 2015;2015(7):CD010033. http:// doi.org/10.1002/14651858.CD010033.pub2. PMid:26222251.
15. Gölz L, Ruppert F, Meier U, Lemcke J. Outcome of modern shunt therapy in patients with idiopathic normal pressure hydrocephalus 6 years postoperatively. J Neurosurg. 2014;121(4):771-5. http://doi. org/10.3171/2014.6.JNS131211. PMid:25061869.
16. Kazui H, Kanemoto H, Yoshiyama K, et al. Association between high biomarker probability of Alzheimer’s disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci. 2016;369:236-41. http:// doi.org/10.1016/j.jns.2016.08.040. PMid:27653897.
17. Pfanner T, Henri-Bhargava A, Borchert S. Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus: a systematic review. Can J Neurol Sci. 2018;45(1):3-10. http://doi.org/10.1017/cjn.2017.251. PMid:29125088.
18. Oertel JMK, Huelser MJM. Predicting the outcome of normal pressure hydrocephalus therapy-where do we stand? Acta Neurochir (Wien). 2021;163(3):767-9. http://doi.org/10.1007/s00701-020-047003. PMid:33474651.
19. Lalou AD, Czosnyka M, Placek MM, Smielewski P, Nabbanja E, Czosnyka Z. CSF dynamics for shunt prognostication and revision in normal pressure hydrocephalus. J Clin Med. 2021;10(8):1711. http:// doi.org/10.3390/jcm10081711. PMid:33921142.
1Department of Neurosurgery, Sree Balaji Medical College and Hospital, Unit of Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India
Received: Sept 04, 2024
Corrected: Mar 10, 2025
Accepted: Mar 10, 202
